Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double-blind randomized controlled trial with two years follow-up
Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double-blind randomized controlled trial with two years follow-up
Background: this study compared the efficacy of an elemental formula (EF) to a polymeric formula (PF) in inducing remission for pediatric Crohn's disease (CD).
Methods: newly diagnosed CD children were randomized to EF or PF for 6 weeks. Change in the Pediatric Crohn's Disease Activity Index (PCDAI), fecal calprotectin, and plasma fatty acids were measured at 0 and 6 weeks. Patients were followed up for 2 years. Time and treatment choice for first relapse were documented.
Results: thirty-four children completed the study; EF: 15 (7 M, 8 F), PF: 19 (13 M, 6 F). The mean age was (years) EF: 12.6, PF: 11.7. Ninety-three percent of children (14/15) achieved remission in the EF group and 79% (15/19) in the PF group. One-third of patients maintained remission for 2 years. Mean time to relapse (days); EF: 183 (63-286), PF: 162 (53-301). Most children who relapsed used feed as a treatment for that relapse (EF: 9/10 and PF: 8/13). With PF, an increase of eicosapentanoic acid (EPA) and alpha linolenic acid was found with a reciprocal decrease in arachidonic acid (AA). With EF, AA and EPA levels were reduced with a significant decrease in docosahexaenoic acid. Fecal calprotectin measurements decreased significantly but did not normalize at the end of week 6.
Conclusions: there was no significant difference between EF and PF in inducing remission. One-third of children maintained remission. Changes in plasma polyunsaturated fatty acid status were subtle and may be relevant; however, further evaluation is recommended
Grogan, Joanne L.
94aeb1b4-771d-4231-b650-11d888cfcab4
Casson, David H.
ee40b3fa-241d-4a40-a1c8-9449525a3675
Terry, Allyson
9464b5e1-d63d-48a4-89dd-b8a48865af2c
Burdge, Graham C.
09d60a07-8ca1-4351-9bf1-de6ffcfb2159
El-Matary, Wael
f0281071-64f1-4ae8-a77e-4f04aebd78a6
Dalzell, A. Mark
a7cd0e8d-37e4-4958-98a9-1ef3ec980f4a
Grogan, Joanne L.
94aeb1b4-771d-4231-b650-11d888cfcab4
Casson, David H.
ee40b3fa-241d-4a40-a1c8-9449525a3675
Terry, Allyson
9464b5e1-d63d-48a4-89dd-b8a48865af2c
Burdge, Graham C.
09d60a07-8ca1-4351-9bf1-de6ffcfb2159
El-Matary, Wael
f0281071-64f1-4ae8-a77e-4f04aebd78a6
Dalzell, A. Mark
a7cd0e8d-37e4-4958-98a9-1ef3ec980f4a
Grogan, Joanne L., Casson, David H., Terry, Allyson, Burdge, Graham C., El-Matary, Wael and Dalzell, A. Mark
(2011)
Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double-blind randomized controlled trial with two years follow-up.
Inflammatory Bowel Diseases.
(doi:10.1002/ibd.21690).
(PMID:21425210)
Abstract
Background: this study compared the efficacy of an elemental formula (EF) to a polymeric formula (PF) in inducing remission for pediatric Crohn's disease (CD).
Methods: newly diagnosed CD children were randomized to EF or PF for 6 weeks. Change in the Pediatric Crohn's Disease Activity Index (PCDAI), fecal calprotectin, and plasma fatty acids were measured at 0 and 6 weeks. Patients were followed up for 2 years. Time and treatment choice for first relapse were documented.
Results: thirty-four children completed the study; EF: 15 (7 M, 8 F), PF: 19 (13 M, 6 F). The mean age was (years) EF: 12.6, PF: 11.7. Ninety-three percent of children (14/15) achieved remission in the EF group and 79% (15/19) in the PF group. One-third of patients maintained remission for 2 years. Mean time to relapse (days); EF: 183 (63-286), PF: 162 (53-301). Most children who relapsed used feed as a treatment for that relapse (EF: 9/10 and PF: 8/13). With PF, an increase of eicosapentanoic acid (EPA) and alpha linolenic acid was found with a reciprocal decrease in arachidonic acid (AA). With EF, AA and EPA levels were reduced with a significant decrease in docosahexaenoic acid. Fecal calprotectin measurements decreased significantly but did not normalize at the end of week 6.
Conclusions: there was no significant difference between EF and PF in inducing remission. One-third of children maintained remission. Changes in plasma polyunsaturated fatty acid status were subtle and may be relevant; however, further evaluation is recommended
This record has no associated files available for download.
More information
e-pub ahead of print date: March 2011
Identifiers
Local EPrints ID: 180915
URI: http://eprints.soton.ac.uk/id/eprint/180915
PURE UUID: 3cfba37e-6fdc-435e-93b3-76f54552a0db
Catalogue record
Date deposited: 13 Apr 2011 13:57
Last modified: 14 Mar 2024 02:54
Export record
Altmetrics
Contributors
Author:
Joanne L. Grogan
Author:
David H. Casson
Author:
Allyson Terry
Author:
Wael El-Matary
Author:
A. Mark Dalzell
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics